Abstract
Objective
The objective of this study was to explore the prognostic value of cancer stem cell markers, namely CD133, NANOG, and NOTCH1, in early stage oral squamous cell carcinoma (OSCC).
Materials and methods
One hundred forty-four patients with early stage (cT1T2N0) OSCC were identified from a pre-existing database of patients with oral cancer. We examined the impact of the immunohistochemical expression of CD133, NANOG, and NOTCH1 in OSCC. Overall survival (OS) curves were calculated using the Kaplan–Meier method. Predictors of outcome were identified using multivariate analysis.
Results
We found that CD133, NANOG, and NOTCH1 were significantly associated with lymph node metastasis, and NOTCH1 was also significantly associated with depth of invasion and locoregional recurrence.
Conclusions
NOTCH1 was identified as an independent prognostic factor for OS.
Clinical relevance
NOTCH1 might prove to be a useful indicator for high-risk patients with occult metastases from early stage OSCC.
Similar content being viewed by others
References
National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) web site. Accessed January 2011.http://seer.cancer.gov/statistics
The 2012 Chinese Cancer Registry Annual Report. Military Science and Technology Press, Beijing, China 2012
Shim SJ, Cha J, Koom WS et al (2010) Clinical outcomes for T1–2N0–1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol 27(5):43
Yuen AP, Ho CM, Chow TL et al (2009) Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 31:765–772
Mücke T, Mitchell DA, Wagenpfeil S et al (2014) Incidence and outcome for patients with occult lymph node involvement in T1and T2 oral squamous cell carcinoma: a prospective study. BMC Cancer 14:346
Ganly I, Patel S, Shah J (2012) Early stage squamous cell cancer of the oral tongue—clinicopathologic features affecting outcome. Cancer 118(1):101–111
Magee JA, Piskounova E, Morrison SJ (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21(3):283–296
Clarke MF, Dick JE, Dirks PB et al (2006) Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66(19):9339–9344
Ghuwalewala S, Ghatak D, Das P et al (2016) CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma. Stem Cell Res 16(2):405–417
Shrivastava S, Steele R, Sowadski M et al (2015) Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep 5:7819
Barns L, Everson JW, Reichart P et al. Pathology and genetics of head and neck tumors[M]. Lyon: IARC Press 168–175
Elsir T, Edqvist P-H, Carlson J et al (2014) A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival. Int J Cancer 134:1123–1131
Hashimoto K, Aoyagi K, Isobe T et al (2014) Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer 17(1):97–106
Sharma BK, Manglik V, O'Connell M et al (2012) Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma. Int J Oncol 41(5):1570–1576
Lee HJ, Kang YH, Lee JS et al (2015) Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma. BMC Oral Health 15(1):153
Shibahara I, Sonoda Y, Saito R et al (2013) The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence. Neuro-Oncology 15(9):1151–1159
Raso A, Mascelli S, Biassoni R et al (2011) High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma. Neuro-Oncology 13:500–508
Arne G, Kristiansson E, Nerman O et al (2011) Expression profiling of GIST:CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis. Int J Cancer 129:1149–1161
Irollov E, Pirozzi G (2013) CD133: to be or not to be, is this the real question? Am J Transl Res 5(6):563–581
Collins AT, Berry PA, Hyde C et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946–10951
O’Brien CA, Pollett A, Gallinger S et al (2007) A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445:106–110
Ravindran G, Sawant SS, Hague A et al (2015) Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis. Head Neck 37:982–993
Chiou SH, Yu CC, Huang CY et al (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14:4085–4095
Watanabe M, Ohnishi Y, Inoue H et al (2014) NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma. Oncol Lett 7:35–40
Li YM, Ma J, Qian XJ et al (2013) Regulation of EMT by Notch signaling pathway in tumor progression. Curr Cancer Drug Targets 13(9):957–962
Zoni E, van der Pluijm G, Gray PC et al (2015) Epithelial plasticity in cancer: unmasking a MicroRNA network for TGF-β, Notch-, and Wnt-mediated EMT. J Oncol 2015:198967
Espinoza I, Pochampally R, Xing F et al (2013) Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther 6:1249–1259
Lee SH, Do SI, Lee HJ et al (2016) Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma. Lab Investig 96(5):508–516
Fakih AR, Rao RS, Borges AM et al (1989) Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 158:309–313
Nakagawa T, Shibuya H, Yoshimura R et al (2003) Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol 68:129–135
Sparano A, Weinstein G, Chalian A et al (2000) Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 122:139–142
Keski-Santti H, Atula T, Tikka J et al (2007) Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 43:1007–1013
Funding
This work was supported by grants from the Doctoral Program Foundation of First Affiliated Hospital of Harbin Medical University in China (no. 2016B015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the First Affiliated Hospitals of Harbin Medical University Institutional Research Board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Wang, S., Fan, H., Xu, J. et al. Prognostic implication of NOTCH1 in early stage oral squamous cell cancer with occult metastases. Clin Oral Invest 22, 1131–1138 (2018). https://doi.org/10.1007/s00784-017-2197-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-017-2197-9